logo

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial - Sight Sciences ( NASDAQ:SGHT )

  4 weeks ago   
post image
MENLO PARK, Calif., Oct. 14, 2024 ( GLOBE NEWSWIRE ) -- Sight Sciences, Inc.
Ticker Sentiment Impact
SGHT
Somewhat Bullish
48 %